Unionized workers at Samsung Biologics, the biotech arm of Samsung Group, extended their historic first strike since the company's 2011 founding into a second day on May 2, 2026. The walkout over wages and other issues shows no signs of resolution after the Friday launch.
SEOUL, May 2 (Yonhap) -- Union officials confirmed that striking workers at Samsung Biologics continued their action Saturday, marking the second day of the biotech firm's first labor walkout since its establishment in 2011.
The ongoing strike follows 13 failed negotiation rounds, with the union demanding a 14 percent raise in base and performance pay, a 30 million won one-off incentive per worker, and 20 percent of annual operating profit as bonuses. The company has offered a 6.2 percent combined increase.
Little progress has been made in bridging differences on wages and other matters. The parties are scheduled for labor ministry mediation talks on Monday.
